Related references
Note: Only part of the references are listed.Cyclosporin and tacrolimus impair insulin secretion and transcriptional regulation in INS-1E beta-cells
L. A. Ozbay et al.
BRITISH JOURNAL OF PHARMACOLOGY (2011)
Plasminogen activator inhibitor-1 5G/5G genotype is a protecting factor preventing posttransplant diabetes mellitus
Horng-Rong Chang et al.
CLINICA CHIMICA ACTA (2011)
Endothelial nitric oxide synthase gene intron 4 polymorphism predicts new onset diabetes mellitus after transplantation in kidney allograft recipients treated with cyclosporin A
Ihsan Ergun et al.
INTERNATIONAL UROLOGY AND NEPHROLOGY (2011)
Unique Cellular and Mitochondrial Defects Mediate FK506-Induced Islet β-Cell Dysfunction
Nassir Rostambeigi et al.
TRANSPLANTATION (2011)
Associations of Pretransplant Diabetes Mellitus, New-Onset Diabetes After Transplant, and Acute Rejection With Transplant Outcomes: An Analysis of the Organ Procurement and Transplant Network/United Network for Organ Sharing (OPTN/UNOS) Database
Hung-Tien Kuo et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2010)
Significant Associations between CCL5 Gene Polymorphisms and Post-Transplantational Diabetes Mellitus in Korean Renal Allograft Recipients
Kyung-Hwan Jeong et al.
AMERICAN JOURNAL OF NEPHROLOGY (2010)
Polymorphisms of Superoxide Dismutase, Glutathione Peroxidase and Catalase Genes in Patients with Post-transplant Diabetes Mellitus
Grazyna Dutkiewicz et al.
ARCHIVES OF MEDICAL RESEARCH (2010)
Effect of CYP3A and ABCB1 Single Nucleotide Polymorphisms on the Pharmacokinetics and Pharmacodynamics of Calcineurin Inhibitors: Part II
Christine E. Staatz et al.
CLINICAL PHARMACOKINETICS (2010)
Calcineurin Signaling Regulates Human Islet β-Cell Survival
Scott A. Soleimanpour et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
β-Cell Secretory Capacity and Demand in Recipients of Islet, Pancreas, and Kidney Transplants
Michael R. Rickels et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
Rapamycin impairs metabolism-secretion coupling in rat pancreatic islets by suppressing carbohydrate metabolism
Makiko Shimodahira et al.
JOURNAL OF ENDOCRINOLOGY (2010)
Pretransplant Risk Factors for New-Onset Diabetes Mellitus After Transplant in Pediatric Liver Transplant Recipients
Hung-Tien Kuo et al.
LIVER TRANSPLANTATION (2010)
Association of calpain-10 gene polymorphism and posttransplant diabetes mellitus in kidney transplant patients medicated with tacrolimus
Mateusz Kurzawski et al.
PHARMACOGENOMICS JOURNAL (2010)
Risk Factors for Development of New-Onset Diabetes Mellitus in Adult Heart Transplant Recipients
Xiaoyi Ye et al.
TRANSPLANTATION (2010)
Risk Factors for New-Onset Diabetes Mellitus in Adult Liver Transplant Recipients, an Analysis of the Organ Procurement and Transplant Network/United Network for Organ Sharing Database
Hung-Tien Kuo et al.
TRANSPLANTATION (2010)
Renal function and cardiovascular risk profile after conversion from ciclosporin to tacrolimus: prospective study in 80 liver transplant recipients
S. Beckebaum et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2009)
New-onset diabetes after transplantation: a review of recent literature
Ashfaq Balla et al.
CURRENT OPINION IN ORGAN TRANSPLANTATION (2009)
Novel insights into glucocorticoid-mediated diabetogenic effects: towards expansion of therapeutic options?
D. H. van Raalte et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2009)
mTORC1 Activation Regulates β-Cell Mass and Proliferation by Modulation of Cyclin D2 Synthesis and Stability
Norman Balcazar et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
TCF7L2 Polymorphism Associates with New-Onset Diabetes after Transplantation
Lidia Ghisdal et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2009)
Pilot Study: Association of Traditional and Genetic Risk Factors and New-Onset Diabetes Mellitus Following Kidney Transplantation
H. A. Chakkera et al.
TRANSPLANTATION PROCEEDINGS (2009)
Mammalian Target of Rapamycin and Diabetes: What Does the Current Evidence Tell Us?
B. Vodenik et al.
TRANSPLANTATION PROCEEDINGS (2009)
Simultaneous islet and kidney transplantation in seven patients with type 1 diabetes and end-stage renal disease using a glucocorticoid-free immunosuppressive regimen with alemtuzumab induction
Jianming Tan et al.
DIABETES (2008)
Sirolimus is associated with new-onset diabetes in kidney transplant recipients
Olwyn Johnston et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2008)
Conversion from cyclosporine to tacrolimus in patients at risk for chronic renal allograft failure: 60-month results of the CRAF study
Fuad S. Shihab et al.
TRANSPLANTATION (2008)
Clinical Relevance and Prevalence of Polymorphisms in CYP3A5 and MDR1 Genes That Encode Tacrolimus Biotransformation Enzymes in Liver Transplant Recipients
L. Barrera-Pulido et al.
TRANSPLANTATION PROCEEDINGS (2008)
A polymorphism in the zinc transporter gene SLC3OA8 confers resistance against posttransplantation diabetes mellitus in renal allograft recipients
Eun Seok Kang et al.
DIABETES (2008)
Activation of the dual-leucine-zipper-bearing kinase and induction of β-cell apoptosis by the immunosuppressive drug cyclosporin A
Silke Plaumann et al.
MOLECULAR PHARMACOLOGY (2008)
A variant of the transcription factor 7-like 2 (TCF7L2) gene and the risk of posttransplantation diabetes mellitus in renal allograft recipients
Eun Seok Kang et al.
DIABETES CARE (2008)
New onset diabetes mellitus after solid organ transplantation
Phuong-Thu T. Pham et al.
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA (2007)
Calcineurin/NFAT signaling in the β-cell:: from diabetes to new therapeutics
Jeremy J. Heit
BIOESSAYS (2007)
Polycystic kidney disease is a risk factor for new-onset diabetes after transplantation
Rizwan A. Hamer et al.
TRANSPLANTATION (2007)
Recovery from diabetes in mice by beta cell regeneration
Tomer Nir et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Early steroid withdrawal therapy in renal transplant recipients: a steroid-free sirolimus and CellCept-based calcineurin inhibitor-minimization protocol
James J. Jaber et al.
CLINICAL TRANSPLANTATION (2007)
Immunosuppressive drug-induced diabetes
A. Penfornis et al.
DIABETES & METABOLISM (2006)
IL-6 promoter polymorphism-174 is associated with new-onset diabetes after transplantation
Jamal Bamoulid et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2006)
Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB
DD Sarbassov et al.
MOLECULAR CELL (2006)
HLA is not predictive of posttransplant diabetes mellitus
L. F. Torres-Romero et al.
TRANSPLANTATION PROCEEDINGS (2006)
Posttransplant diabetes mellitus in kidney transplant recipients receiving calcineurin or mTOR inhibitor drugs
M Araki et al.
TRANSPLANTATION (2006)
Facilitating physiologic self-regeneration: A step beyond islet cell replacement
PPM Rood et al.
PHARMACEUTICAL RESEARCH (2006)
Dexamethasone suppresses phospholipase C activation and insulin secretion from isolated rat islets
WS Zawalich et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2006)
New onset hyperglycemia and diabetes are associated with increased cardiovascular risk after kidney transplantation
FG Cosio et al.
KIDNEY INTERNATIONAL (2005)
Incidence and risk factors of clinical characteristics, tacrolimus pharmacokinetics, and related genomic polymorphisms for posttransplant diabetes mellitus in the early stage of renal transplant recipients
K Numakura et al.
TRANSPLANTATION PROCEEDINGS (2005)
Serum- and glucocorticoid-inducible kinase 1 (SGK1) mediates glucocorticoid-induced inhibition of insulin secretion
S Ullrich et al.
DIABETES (2005)
Tacrolimus suppresses glucose-induced insulin release from pancreatic islets by reducing glucokinase activity
RG Radu et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2005)
New-Onset Posttransplantation Diabetes Mellitus: Insulin Resistance or Insulinopenia? Impact of Immunosuppressive Drugs, Cytomegalovirus and Hepatitis C Virus Infection
Joran Hjelmesth et al.
CURRENT DIABETES REVIEWS (2005)
Aged transgenic mice with increased glucocorticoid sensitivity in pancreatic β-cells develop diabetes
B Davani et al.
DIABETES (2004)
Insulin resistance after renal transplantation:: The effect of steroid dose reduction and withdrawal
K Midtvedt et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2004)
Hepatitis C virus down-regulates insulin receptor substrates 1 and 2 through up-regulation of suppressor of cytokine signaling 3
T Kawaguchi et al.
AMERICAN JOURNAL OF PATHOLOGY (2004)
Tacrolimus impairment of insulin secretion in isolated rat islets occurs at multiple distal sites in stimulus-secretion coupling
Y Uchizono et al.
ENDOCRINOLOGY (2004)
Posttransplantation diabetes - A systematic review of the literature
VM Montori et al.
DIABETES CARE (2002)
Insulin release and suppression by tacrolimus, rapamycin and cyclosporin A are through regulation of the ATP-sensitive potassium channel
DK Fuhrer et al.
DIABETES OBESITY & METABOLISM (2001)
Share Paper
